Skip to main content
Cisen Pharmaceutical Co.,Ltd. logo

Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 603367 ISIN · CNE100002VG4 LEI · 836800T7RRJXURVHYS35 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,110 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603367

About Cisen Pharmaceutical Co.,Ltd.

https://www.cisen-pharma.com/

Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺（蔡弘）
Regulatory Filings Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, compliance with regulatory requirements, and independence criteria. It does not contain financial data, audit information, or report content. It is not an announcement of voting results or a proxy solicitation. It is a regulatory compliance statement related to board membership qualifications. Therefore, it fits best under Regulatory Filings (RNS) as a compliance document that does not fit other specific categories.
2023-12-29 Chinese
独立董事提名人声明与承诺（蔡文春）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board, detailing qualifications, compliance with laws and regulations, and declarations of independence. It is a declaration related to board/management changes rather than a financial report, regulatory filing, or meeting material. The content aligns with announcements about board or management information, specifically the nomination of a board member.
2023-12-29 Chinese
辰欣药业股份有限公司第四届监事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions from the 24th meeting of the 4th Supervisory Board of the company, including nominations for the 5th Supervisory Board non-employee representative supervisors. It details meeting attendance, voting results, and candidate biographies. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and nominations, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is MANG with high confidence.
2023-12-29 Chinese
独立董事候选人声明与承诺（蔡文春）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, compliance with regulatory requirements, and independence criteria. It does not contain financial data, audit results, or report content. It is not an announcement of a report publication but a formal statement related to board/management information, specifically about a director candidate's qualifications and commitments. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on director candidacy, not a financial or regulatory report.
2023-12-29 Chinese
独立董事候选人声明与承诺（顾维军）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, compliance with laws and regulations, and independence criteria. It is not a financial report, earnings release, or any form of regulatory filing related to financial performance or corporate governance changes. It is a formal statement related to board/management information, specifically about the nomination and qualifications of an independent director candidate. The document length is short (2304 characters), and it contains detailed personal declarations rather than announcements or summaries. Therefore, it fits best under Board/Management Information (MANG).
2023-12-29 Chinese
辰欣药业股份有限公司关于董事会监事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and nomination of the company's board of directors and supervisory board members. It details the candidates for the new board and supervisory board, their qualifications, and the procedures followed according to company law and regulations. There is no financial data, earnings information, or audit content. The document is not a report but an official announcement about changes in the company's board and supervisory committee. This fits the category of Board/Management Information (MANG). The document length is over 6000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2023-12-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.